Cargando…

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis

BACKGROUND: Allergen-specific immunotherapy, including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), improves the disease progression of allergic rhinitis (AR). SCIT and SLIT exhibit similar efficacy, but SLIT has less systemic reactions. However, few studies have investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Yinhui, Xiao, Haiqing, Gao, Shengli, Li, Jinyuan, Yang, Chao, Zeng, Qingxiang, Luo, Xi, Luo, Renzhong, Chen, Xi, Liu, Wenlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2023
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382672/ https://www.ncbi.nlm.nih.gov/pubmed/37520614 http://dx.doi.org/10.1016/j.waojou.2023.100803

Ejemplares similares

Association between the genetic variants of base excision repair pathway genes and allergic rhinitis susceptibility in Chinese children
por: Liu, Wenlong, et al.
Publicado: (2022)

Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis
por: Liu, Wenlong, et al.
Publicado: (2020)

Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
por: Zeng, Qingxiang, et al.
Publicado: (2023)

Genetic Variations in Nucleotide Excision Repair Pathway Genes and Risk of Allergic Rhinitis
por: Liu, Wenlong, et al.
Publicado: (2022)

Osteopontin mediated eosinophils activation by group II innate lymphoid cells
por: Zeng, Qingxiang, et al.
Publicado: (2022)

MicroRNA-375-mediated regulation of ILC2 cells through TSLP in allergic rhinitis
por: Luo, Xi, et al.
Publicado: (2020)

Leptin Regulated ILC2 Cell through the PI3K/AKT Pathway in Allergic Rhinitis
por: Zeng, Qingxiang, et al.
Publicado: (2020)

The Inhibition of Group II Innate Lymphoid Cell Response by IL-27 in Allergic Rhinitis
por: Luo, Xi, et al.
Publicado: (2020)

Correlation between Serum Osteopontin and miR-181a Levels in Allergic Rhinitis Children
por: Liu, Wenlong, et al.
Publicado: (2016)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
por: Kulalert, Prapasri, et al.
Publicado: (2022)

High density lipoprotein inhibited group II innate lymphoid cells proliferation and function in allergic rhinitis
por: Gao, Shengli, et al.
Publicado: (2022)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Combination of mometasone furoate and oxymetazoline for the treatment of adenoid hypertrophy concomitant with allergic rhinitis: A randomized controlled trial
por: Liu, Wenlong, et al.
Publicado: (2017)

Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis
por: Abdullah, Baharudin, et al.
Publicado: (2023)

Leptin/Osteopontin Axis Regulated Type 2T Helper Cell Response in Allergic Rhinitis with Obesity
por: Zeng, Qingxiang, et al.
Publicado: (2018)

Leptin Promoted IL-17 Production from ILC2s in Allergic Rhinitis
por: Wen, Yanhui, et al.
Publicado: (2020)

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis
por: Huang, Jingyu, et al.
Publicado: (2023)

Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis
por: Zhou, Yandan, et al.
Publicado: (2022)

Role of Leptin/Osteopontin Axis in the Function of Eosinophils in Allergic Rhinitis with Obesity
por: Liu, Wenlong, et al.
Publicado: (2018)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
por: Aboshady, Omar Ali, et al.
Publicado: (2014)

Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016)

Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023)

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Poster 2022: Sublingual immunotherapy in the treatment of allergic rhinitis: series of cases
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2014)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022)

Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
por: Wang, Jiarong, et al.
Publicado: (2021)

Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial
por: Lou, Hongfei, et al.
Publicado: (2020)

The relationship between sublingual immunotherapy for allergic rhinitis and the risk of symptoms in patients with COVID-19 infection
por: Zhang, Shipeng, et al.
Publicado: (2023)

Changes of allergic inflammation and immunological parameters after Alt a 1 and A. alternata immunotherapy in mice
por: Liu, Juan, et al.
Publicado: (2023)

Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis
por: Chiang, Tsai-Yeh, et al.
Publicado: (2022)

Allergic rhinitis in Chinese young adults from the Singapore/Malaysia cross-sectional genetics epidemiology study (SMCGES) cohort: Prevalence, patterns, and epidemiology of allergic rhinitis
por: Wong, Qi Yi Ambrose, et al.
Publicado: (2022)

Outcome of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitive to House Dust Mites
por: Kim, Seon-Tae
Publicado: (2015)

Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis
por: Li, Jiang-hua, et al.
Publicado: (2019)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis
por: Ji, Zao, et al.
Publicado: (2023)

Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis
por: Wang, Xiaoqiang, et al.
Publicado: (2023)

Specific immunoglobulin G4 correlates with Th2 cytokine reduction in patients with allergic asthma treated by Dermatophagoides pteronyssinus subcutaneous immunotherapy
por: Su, Qiujuan, et al.
Publicado: (2023)

Early Compliance and Efficacy of Sublingual Immunotherapy in Patients with Allergic Rhinitis for House Dust Mites
por: Chang, Hyun, et al.
Publicado: (2009)

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
por: Frati, Franco, et al.
Publicado: (2014)

Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
por: De Oliveira Santos, Júlia Gaspar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ffciqfjlhv29shjstiq3lmqdi